stockrow
Saturday 7 November 2026
Export OABI’s income statement to Excel — free account
OmniAb, Inc.
OABI Healthcare Biotechnology
OmniAb, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $18.7 million, down 29.3% from fiscal 2024.
- Revenue
- +78.3%
- EPS
- +14.3%
- Free cash flow
- +206.3%
Quarter to September 2026, against a year earlier
5.02
0.19
+3.93%
Follow OABI
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
2 | 5 | 5 | 5 |
| (23.36%) | (20.25%) | (16.95%) | (16.51%) | ||
| (20.68%) | (18.10%) | (15.11%) | (14.48%) | ||
ROIC |
(20.24%) | (16.96%) | (14.52%) | (15.75%) | |
Return on Tangible Assets |
(110.70%) | (89.61%) | (72.90%) | (70.05%) | |
Average Days of Receivables |
144.51 | 159.41 | 98.02 | 23.36 | |
Free Cash Flow per Share |
(0.30) | (0.18) | (0.14) | 0.02 | |
Free Cash Flow |
(34.02) | (23.02) | (18.14) | 2.38 | |
Capital Expenditures |
2.44 | 2.48 | (0.47) | (0.29) | |
| Other line items | |||||
Cash ROIC |
(10.60%) | (7.38%) | (5.81%) | 0.76% | |
Accounts Receivable Turnover |
2.95 | 3.03 | 5.90 | 14.19 | |
Accounts Payable Turnover |
0.15 | 0.18 | 0.33 | 0.57 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
2,263.48 | 1,914.22 | 1,149.50 | 543.82 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.02) | (0.02) | (0.03) | (0.01) | |
Research and Development Expense of Revenue |
255.83% | 154.78% | 113.15% | 106.16% | |
Selling, General and Administrative Expense of Revenue |
156.51% | 96.48% | 69.92% | 68.03% | |
Share Based Compensation of Revenue |
84.77% | 51.90% | 36.58% | 32.73% | |
Operating CF/Net income |
0.56 | 0.47 | 0.40 | (0.06) | |
Depreciation/Fixed assets |
2.22 | 2.59 | 2.72 | 2.84 | |
Capex/Depreciation |
0.12 | 0.11 | (0.02) | (0.01) | |
Revenue per Share |
0.16 | 0.23 | 0.30 | 0.31 | |
Operating CF per Share |
(0.32) | (0.20) | (0.14) | 0.02 | |
Capex per Share |
0.02 | 0.02 | 0.00 | 0.00 | |
Capex to Sales |
(0.13) | (0.09) | 0.01 | 0.01 |
Columns are period end dates · fundamentals updated 6 Nov 2026